Upgrade to SI Premium - Free Trial

Natera (NTRA)

264.22 -2.96 (1.11%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Natera's Signatera outperforms AMERK in skin cancer recurrence study July 22, 2026 6:02 AM - StreetInsider Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study July 22, 2026 6:00 AM - BizWire Form 4 Natera, Inc. For: Jul 15 Filed by: Chapman Rowan E July 17, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Jul 15 Filed by: Sheena Jonathan July 17, 2026 9:05 PM - SEC Filing Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio July 16, 2026 6:35 PM - BizWire Form 4 Natera, Inc. For: Jul 13 Filed by: Sheena Jonathan July 15, 2026 9:05 PM - SEC Filing Form 144 Natera, Inc. Filed by: Chapman Rowan E July 15, 2026 4:13 PM - SEC Filing Form 144 Natera, Inc. Filed by: Sheena Jonathan July 15, 2026 10:11 AM - SEC Filing Natera (NTRA) PT Raised to $330 at Canaccord July 14, 2026 6:42 AM - StreetInsider Form 144 Natera, Inc. Filed by: Sheena Jonathan July 13, 2026 11:05 AM - SEC Filing Natera (NTRA) PT Raised to $329 at Baird July 13, 2026 7:18 AM - StreetInsider Natera (NTRA) PT Raised to $310 at Morgan Stanley July 9, 2026 8:16 AM - StreetInsider Natera's Signatera wins EU IVDR certification for multiple cancers July 9, 2026 6:01 AM - StreetInsider Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers July 9, 2026 6:00 AM - BizWire Form 4 Natera, Inc. For: Jul 06 Filed by: Rabinowitz Matthew July 8, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Jul 01 Filed by: RABINOWITZ DANIEL July 6, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Jul 01 Filed by: Moshkevich Solomon July 6, 2026 9:05 PM - SEC Filing Form 144 Natera, Inc. Filed by: Rabinowitz Matthew July 6, 2026 4:56 PM - SEC Filing Monica Bertagnolli resigns from Natera board for National Academy of Medicine role July 6, 2026 4:12 PM - StreetInsider Form 8-K Natera, Inc. For: Jul 01 July 6, 2026 4:05 PM - SEC Filing Natera's Signatera test linked to survival benefit in colon cancer July 6, 2026 6:00 AM - StreetInsider Signatera™ MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer July 6, 2026 6:00 AM - BizWire Form 144 Natera, Inc. Filed by: RABINOWITZ DANIEL July 1, 2026 4:16 PM - SEC Filing Form 144 Natera, Inc. Filed by: Moshkevich Solomon July 1, 2026 4:14 PM - SEC Filing Form 4 Natera, Inc. For: Jun 26 Filed by: Marcus Gail Boxer June 30, 2026 8:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 26 Filed by: Rubin Eric H June 30, 2026 8:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 26 Filed by: ROSENMAN HERM June 30, 2026 8:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 26 Filed by: BOTHA ROELOF June 30, 2026 8:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 26 Filed by: Lynch Thomas J. Jr. June 30, 2026 8:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 26 Filed by: Chapman Rowan E June 30, 2026 8:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 26 Filed by: Bertagnolli Monica June 30, 2026 8:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 26 Filed by: Baynes Roy D. June 30, 2026 8:05 PM - SEC Filing Natera (NTRA) PT Raised to $290 at Guggenheim June 29, 2026 6:55 AM - StreetInsider Natera and Aveta Biomics partner on phase 3 head and neck cancer trial June 29, 2026 6:01 AM - StreetInsider Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer June 29, 2026 6:00 AM - BizWire Form 4 Natera, Inc. For: Jun 24 Filed by: RABINOWITZ DANIEL June 26, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 24 Filed by: ROSENMAN HERM June 26, 2026 9:05 PM - SEC Filing Bernstein SocGen Group Resumes Natera (NTRA) at Outperform June 26, 2026 6:08 AM - StreetInsider Natera and Eledon partner on kidney transplant Phase 3 trial June 25, 2026 7:00 AM - StreetInsider Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial June 25, 2026 7:00 AM - BizWire Form 144 Natera, Inc. Filed by: RABINOWITZ DANIEL June 24, 2026 4:37 PM - SEC Filing Form 144 Natera, Inc. Filed by: ROSENMAN HERM June 24, 2026 4:21 PM - SEC Filing Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer June 24, 2026 5:00 AM - BizWire Natera's Signatera wins Japan approval for colorectal cancer June 24, 2026 3:15 AM - StreetInsider Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer June 24, 2026 3:00 AM - BizWire Natera (NTRA) PT Lowered to $260 at Barclays June 24, 2026 2:59 AM - StreetInsider Natera (NTRA) PT Raised to $270 at BTIG June 23, 2026 3:48 PM - StreetInsider NCCN adds Natera's Signatera to bladder cancer treatment guidelines June 23, 2026 6:01 AM - StreetInsider NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update June 23, 2026 6:00 AM - BizWire Form 4 Natera, Inc. For: Jun 17 Filed by: Sheena Jonathan June 22, 2026 9:05 PM - SEC Filing Natera to present 21 studies on transplant test at ATC June 18, 2026 6:01 AM - StreetInsider Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress June 18, 2026 6:00 AM - BizWire Form 4 Natera, Inc. For: Jun 15 Filed by: Sheena Jonathan June 17, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 16 Filed by: Chapman Rowan E June 17, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 12 Filed by: Rabinowitz Matthew June 16, 2026 9:35 PM - SEC Filing Natera board expands to 12 with appointment of Thomas Lynch June 16, 2026 4:11 PM - StreetInsider Form 8-K/A Natera, Inc. For: Jun 02 June 16, 2026 4:09 PM - SEC Filing Form 8-K Natera, Inc. For: Jun 11 June 16, 2026 4:08 PM - SEC Filing Form 144 Natera, Inc. Filed by: Chapman Rowan E June 16, 2026 4:03 PM - SEC Filing Form 144 Natera, Inc. Filed by: Rabinowitz Matthew June 12, 2026 4:42 PM - SEC Filing RBC Capital Starts Natera (NTRA) at Outperform June 11, 2026 4:06 PM - StreetInsider Form 4 Natera, Inc. For: Jun 05 Filed by: Marcus Gail Boxer June 9, 2026 9:05 PM - SEC Filing Form 3 Natera, Inc. For: Jun 02 Filed by: Lynch Thomas J. Jr. June 9, 2026 6:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 04 Filed by: Chapman Steven Leonard June 5, 2026 9:05 PM - SEC Filing Form 144 Natera, Inc. Filed by: Marcus Gail Boxer June 5, 2026 5:15 PM - SEC Filing Form 8-K Natera, Inc. For: Jun 02 June 5, 2026 4:08 PM - SEC Filing Goldman Sachs Starts Natera (NTRA) at Neutral June 5, 2026 2:33 AM - StreetInsider Form 144 Natera, Inc. Filed by: Chapman Steven Leonard June 4, 2026 5:04 PM - SEC Filing Natera partners with CytoDyn for colorectal cancer drug development June 4, 2026 8:01 AM - StreetInsider Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer June 4, 2026 8:00 AM - BizWire Form 4 Natera, Inc. For: Jun 01 Filed by: Moshkevich Solomon June 3, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: May 29 Filed by: Rubin Eric H June 3, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 01 Filed by: BOTHA ROELOF June 3, 2026 4:40 PM - SEC Filing Natera adds oncology experts Lynch and Rubin to board of directors June 3, 2026 8:01 AM - StreetInsider Natera Appoints Oncology Leaders Drs. Thomas Lynch and Eric Rubin to Board of Directors June 3, 2026 8:00 AM - BizWire Wolfe Research Assumes Natera (NTRA) at Outperform June 1, 2026 4:24 PM - StreetInsider Form 144 Natera, Inc. Filed by: BOTHA ROELOF June 1, 2026 4:13 PM - SEC Filing Form 144 Natera, Inc. Filed by: Moshkevich Solomon June 1, 2026 4:07 PM - SEC Filing Natera (NTRA) Announces Collaboration with Diakonos Oncology for Signatera in Refractory Melanoma May 29, 2026 6:03 AM - StreetInsider Natera Announces Collaboration with Diakonos Oncology for Signatera™ in Refractory Melanoma May 29, 2026 6:00 AM - BizWire Form 4 Natera, Inc. For: May 26 Filed by: Fesko John May 28, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: May 26 Filed by: Moshkevich Solomon May 28, 2026 9:05 PM - SEC Filing Natera Enrolls First Patients in SIGNAL-ER 101, a Prospective, Interventional Study Evaluating MRD-Guided Therapy in Breast Cancer May 28, 2026 6:00 AM - BizWire Natera enhances Panorama prenatal test with deep sequencing technology May 26, 2026 6:02 AM - StreetInsider Natera to Launch Enhanced Panorama™ NIPT, Powered by Novel SNP-Informed Deep Sequencing Technology May 26, 2026 6:00 AM - BizWire Natera to present 35 studies at ASCO meeting on cancer diagnostics May 21, 2026 5:05 PM - StreetInsider Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology May 21, 2026 5:05 PM - BizWire Natera expands Austin operations, plans what it calls world's largest sequencing facility May 21, 2026 7:00 AM - StreetInsider Natera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the World May 21, 2026 7:00 AM - BizWire Natera's fetal genetic testing trial enrolls over 2,000 patients May 20, 2026 7:02 AM - StreetInsider EXPAND Trial of Natera’s Fetal Focus™ Single-Gene NIPT Surpasses >2,000 Patients Enrolled May 20, 2026 7:00 AM - BizWire Form 4 Natera, Inc. For: May 08 Filed by: Sheena Jonathan May 15, 2026 9:05 PM - SEC Filing FDA approves Natera's Signatera CDx for bladder cancer treatment decisions May 15, 2026 12:55 PM - StreetInsider Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) May 15, 2026 12:45 PM - BizWire FDA approves Genentech's Tecentriq for bladder cancer treatment May 15, 2026 12:32 PM - StreetInsider Natera (NTRA) PT Lowered to $250 at BTIG May 11, 2026 8:44 AM - StreetInsider Natera (NTRA) PT Raised to $265 at Baird May 8, 2026 7:58 AM - StreetInsider Natera (NTRA) PT Raised to $220 at Wells Fargo May 8, 2026 6:56 AM - StreetInsider Form 10-Q Natera, Inc. For: Mar 31 May 8, 2026 6:06 AM - SEC Filing Natera (NTRA) Misses Q1 EPS by 6c; raises guidance May 7, 2026 4:42 PM - StreetInsider Form 8-K Natera, Inc. For: May 07 May 7, 2026 4:13 PM - SEC Filing Natera Reports First Quarter 2026 Financial Results May 7, 2026 4:05 PM - BizWire Form 4 Natera, Inc. For: May 04 Filed by: Rabinowitz Matthew May 6, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Brophy Michael Burkes May 5, 2026 9:45 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Chapman Steven Leonard May 5, 2026 9:36 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Fesko John May 5, 2026 9:36 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Sheena Jonathan May 5, 2026 9:36 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Moshkevich Solomon May 5, 2026 9:36 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: RABINOWITZ DANIEL May 5, 2026 9:35 PM - SEC Filing Form 144 Natera, Inc. Filed by: Brophy Michael Burkes May 4, 2026 4:53 PM - SEC Filing Form 144 Natera, Inc. Filed by: Moshkevich Solomon May 1, 2026 4:09 PM - SEC Filing Form SCHEDULE 13G Natera, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 11:29 AM - SEC Filing Natera to Report its First Quarter Results on May 7, 2026 April 30, 2026 8:00 AM - BizWire Form 4 Natera, Inc. For: Apr 27 Filed by: Brophy Michael Burkes April 29, 2026 9:45 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: Chapman Steven Leonard April 29, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: RABINOWITZ DANIEL April 29, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: Sheena Jonathan April 29, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: Fesko John April 29, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: Moshkevich Solomon April 29, 2026 9:35 PM - SEC Filing Form 144 Natera, Inc. Filed by: Brophy Michael Burkes April 29, 2026 4:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Marcus Gail Boxer April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Bertagnolli Monica April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Chapman Rowan E April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: BOTHA ROELOF April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Baynes Roy D. April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Rubin Eric H April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: ROSENMAN HERM April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Williams Brinkley Ruth April 28, 2026 8:35 PM - SEC Filing Barclays: Life science insiders sold $187M in stock during first quarter April 28, 2026 9:18 AM - StreetInsider Form ARS Natera, Inc. For: Dec 31 April 23, 2026 7:03 PM - SEC Filing Form DEFA14A Natera, Inc. April 23, 2026 7:03 PM - SEC Filing Form DEF 14A Natera, Inc. For: Jun 11 April 23, 2026 7:03 PM - SEC Filing Full Article List